TuesdayMay 04, 2021 3:00 pm

Ancient Spiritual Psychedelic Practices May Aid the Legalization Movement

The legalization of marijuana is often considered to be a model for psychedelics. Thus far, marijuana has been legalized for both medical and recreational use in various nations across the globe and in numerous states in the United States. From the above, one can deduce that there are two primary ways to end the ban on psychedelics: decriminalization or medicalization. However, while those two options are effective, they conceal another way of using psychedelics: obtaining legal sanction for the religious or spiritual use of psychedelics that are considered sacred tools for holy rituals in various traditions. Here, we are referring…

Continue Reading

TuesdayMay 04, 2021 2:24 pm

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Inks Distribution Agreement for Rapid COVID-19 Test Kits; Expands Commercial Leadership Team in Anticipation of Strong, Sustainable Sales 

XPhyto Therapeutics Corp. recently announced it has entered into a distribution, storage and logistics agreement with a German distributor with an established network throughout Germany Germany holds promise due to regulations requiring mandatory weekly testing for its citizens; this has the possibility of ramping up sales Anticipating the increase in sales and distribution, XPhyto expanded its commercial leadership team by bringing on board Mr. Wolfgang Probst and Mr. Manfred Buchberger Mr. Probst will be the company’s Chief Operations Officer (“COO”), while Mr. Buchberger will be the Head of Corporate Development at wholly owned subsidiary XP Diagnostics GmbH The approvals XPhyto…

Continue Reading

TuesdayMay 04, 2021 11:44 am

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Leading Charge in Developing Psychedelic Medicines for Treating Rare Eating Disorders

Pharmaceutical developer Tryp Therapeutics is targeting orphan disorders with novel medicinal solutions The company’s initial candidates seeking regulatory approval are a psilocybin compound for treating fibromyalgia, eating disorders and chronic pain conditions, as well as a tumor-inhibiting drug for treating soft tissue sarcomas Tryp has partnered with the University of Florida to conduct a Phase 2a clinical trial for eating disorders using Tryp's psilocybin product Following a year in which a global pandemic led to heightened concerns about individuals’ mental well-being while navigating the health emergency’s effects on society (https://ibn.fm/YGqDb), proponents of psychedelic medicine development programs gained stronger allies in…

Continue Reading

MondayMay 03, 2021 3:00 pm

Scientists Criticize Drug War at Psychedelics Event Hosted by Federal Health Agency

Last week, a federal health agency begun a speaker series that will be focused on reviewing the science behind psilocybin mushrooms and the therapeutic potential they possess. Experts who aired their views at the inaugural event claimed that federal drug regulations undermined the scientific community’s research objectives and weren’t in line with what the voters wanted. The event is being hosted by the National Cancer Institute, under the National Institutes of Health (“NIH”). The institute notes that it has some clinical trials looking into the use of psilocybin as a treatment of cancer-related depression, with others exploring the psychedelic’s potential…

Continue Reading

MondayMay 03, 2021 12:57 pm

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Makes Headway into Canadian Cannabis Vape Market with 25,000 Unit Production Run

Production underway for 25,000 vape cartridges using PULL full spectrum oil formulations, including Super Lemon Haze, Grand Daddy Purple and Girl Scout Cookies/GSK Company estimates retail sales revenue for this production run will be approximately $750,000 60% of respondents in StatCan’s Canadian 2020 Cannabis Survey that used vaporizer for cannabis in the last 12 months used oil/extracts “Cannabis 2.0,” the colloquial term for legalization of cannabis derivatives in Canada late in 2019, represented the outset of new trends in how people consume cannabis products with the accessibility of goods like drinks and vape products. While some companies have devoted considerable…

Continue Reading

FridayApr 30, 2021 2:00 pm

Community-Based Psychedelic Organizations Key to Future Psychedelic Treatment Accessibility

Psychedelics have become a popular topic of discussion and research, with some states, including Oregon, going so far as to legalize psilocybin-assisted therapy, and the Multidisciplinary Association of Psychedelic Studies advancing MDMA-assisted therapy through the FDA as a treatment for post-traumatic stress disorder. However, despite the progress made in learning more about these substances along with the benefits they possess and how they can be used as alternative treatments for various illnesses, the presence of large for-profit companies, which keep obtaining patents that make them the primary option for psychedelic therapies in the near future, keeps growing at a rather…

Continue Reading

FridayApr 30, 2021 1:56 pm

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Is ‘One to Watch’

Tryp Therapeutics is a pharmaceutical company with a focus on developing clinical-stage compounds for diseases with high unmet medical needs through accelerated regulatory pathways The company currently has two drug candidates in development: TRP-8802 (targeting fibromyalgia, eating disorders and chronic pain conditions); and TRP-1001 (targeting soft tissue sarcomas) Through its PFN(TM) program, the company is focused on developing psilocybin-based drug therapies for certain neuropsychiatric disorders that offer increased efficacy and reduced risk of abuse or addiction The company’s management team has decades of experience in the life sciences industry, including the pharmaceutical and biotechnology markets Oncology therapeutics are expected to…

Continue Reading

ThursdayApr 29, 2021 2:30 pm

Serial Entrepreneur Starts First Psychedelic Food Truck

Cynthia Cummings, a serial entrepreneur who is constantly redefining herself, is doing it again Cummings, who is always ready for a new adventure, recently set up a food truck in Royal Bay, British Columbia. The food truck has something for everyone, from juicy burgers and greasy fries to healthy wraps. Cummings has more than a decade’s worth of experience in this area, having run hot dog stands and food trucks for the nightclub crowds for more than 15 years in Toronto. She thought of setting up a food truck after observing that many individuals in the West Shore preferred going…

Continue Reading

WednesdayApr 28, 2021 3:00 pm

Trial Finds Psilocybin May Work as Effectively as Common Antidepressants

A clinical trial whose results were published last week has found that psilocybin may be used to treat depression. The phase 2 study was the first randomized trial that compared the effectiveness of commonly prescribed antidepressants with therapeutic doses of psilocybin. Its findings were reported in the “New England Journal of Medicine.” The trial was conducted by scientists from the Imperial College London. Despite the reported findings, there is still more that needs to be determined with regard to the use of psychedelics as a treatment for various mental health conditions, as researchers aren’t sure whether the substances, psilocybin included,…

Continue Reading

WednesdayApr 28, 2021 11:56 am

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Retail Business to Bloom This Spring With Production of 50,000 Blister Packs

PULL starts production of roughly 50,000 blister pack gummies using Taste-T LLC’s successful proprietary manufacturing system Global CBD gummies market size estimated to grow at CAGR of 31.9% until 2025 PULL estimates $200,000 in revenue from initial batch, plans to produce three additional non-THC SKUs with varying levels of ultra-high potency CBD Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, recently announced it started production on roughly 50,000 Pure Chews edible gummy packs to be sold this Spring (https://ibn.fm/aEibn). The news came shortly…

Continue Reading

PsychedelicNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000